US FDA drafts guidance on aspirin labelling

16 January 2017 - Deborah Wilkes

Archived

The US Food and Drug Administration (FDA) is encouraging companies that market OTC aspirin products with "cardiovascular-related imagery" to remind consumers to consult a healthcare professional.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: